期刊文献+

自体树突状细胞体外增强肿瘤患者引流淋巴结细胞抗肿瘤活性的作用 被引量:10

Enhancing antitumor activity of tumor-draining lymph node cells by autologous dendritic cells
原文传递
导出
摘要 目的 :探讨自体树突状细胞 (DC)体外对胃腺癌患者肿瘤引流区淋巴结 (TDLN)细胞抗肿瘤活性的增强作用。方法 :分离肿瘤患者的外周血单个核细胞 (PBMC)经IL 4、GM CSF和TNF α诱导其成熟 ,并以自体肿瘤冻融抗原预致敏 ,诱导其中的DC。另外 ,分离胃癌患者的TDLN细胞 ,在含有IL 2的培养体系中培养 ,并将TDLN细胞分为 3组 :(1)第 1组为肿瘤抗原致敏的DC加TDLN细胞 (D组 ) ;(2 )第 2组为冻融的肿瘤抗原加TDLN细胞 (Ag组 ) ;(3)第 3组不加DC及肿瘤抗原作为对照组 (L组 )。比较 3组TDLN细胞对胃腺癌细胞系KATO3和黑色素瘤细胞系A375的杀伤作用。结果 :D组对KATO3细胞系的杀伤作用明显优于Ag组与L组 ;而对A375细胞 ,各组细胞的杀伤作用没有明显差异。结论 AIM: To enhance antitumor activity of tumor-draining lymph node(TDLN) cells by autologous dendritic cells(DCs) in vitro. METHODS: Peripheral blood mononuclear cells(PBMCs) were isolated from the patients with gastric adenocarcinoma and induced with GM-CSF, IL-4 and TNF-α to obtain mature DCs which were then sensitized by autologous tumor lysate. TDLN cells were isolated and purified from lymph nodes of the patients and incubated with IL-2. Then we designed three experiment groups: (1)first group: TDLN cells activated by sensitized DCs; (2) second group:TDLN cells activated by autologous tumor lysate; (3)third group: TDLN cells alone, which were used as control. Cytotoxic activity of TDLN cells to gastric adenocarcinoma cell line KATO3 and human melanoma cell line A375 were compared between 3 groups. RESULTS: The cytotoxicity of TDLN cells activated by sensitized DCs to KATO3 cells was significantly stronger than that of TDLN cells activated by autologous tumor lysate or TDLN cells alone. In contrast, for A375 cells, cytotoxic activities of three TDLN cells had no significant difference. CONCLUSION: Specific antitumor activity of TDLN cells can be enhanced significantly by activated autologous DCs.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2004年第5期595-597,607,共4页 Chinese Journal of Cellular and Molecular Immunology
关键词 自体 杀伤作用 肿瘤患者 体外 肿瘤抗原 黑色素瘤细胞 引流 胃腺癌细胞 抗肿瘤活性 培养体系 tumor-draining region lymph node cells dendritic cells antitumor activity
  • 相关文献

参考文献7

  • 1Lores B, Garca-Estevez JM, Arias C, et al. Lymph nodes and human tumors (review) [J]. Int J Mol Med, 1998, 1: 729 -733.
  • 2Sameshima S, Sakai K, Nagawa H, et al. Correlation of the therapeutic effect of activated tumor-draining lymph node cells with specific interferon-gamma production in vitro [ J ]. Surg Today, 1999, 29:55 - 62.
  • 3Aruga A, Aruga E, Tanigawa K, et al. Type 1 versus type 2 cytokine release by Vbeta T cell subpopulations determines in vivo antitumor reactivity: IL-10 mediates a suppressive role [ J ]. J Immunol, 1997,159:664-673.
  • 4Tanigawa K, Takeshita N, Craig RA, et al. Tumor-specific responses in lymph nodes draining murine sarcomas are concentrated in cells expressing P-selectin binding sites[J]. J Immunol, 2001, 167:3089- 3098.
  • 5Santi AD. Microenvironment of lymph node matastases[J]. Cancer,2000, 88(1): 175 -179.
  • 6Cohen PA, Peng L, Kjaergaard J, et al. T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance [J]. Crit Rev Immunol, 2001, 21: 215 -248.
  • 7Almand B, Resser JR, Lindman B, et al. Clinical significance of defective dendriticcell differentiation in cancer[ J]. Clin Cancer Res,2000, 6: 1755 - 1766.

同被引文献88

引证文献10

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部